RSLS

ReShape Lifesciences has agreed to be acquired by Vyome Therapeutics, Inc. After the completion of the proposed transaction, ReShape shareholders will own approximately 11.1% of the combined entity, subject to adjustment depending on ReShape’s actual net cash at the time of closing compared to the target net cash amount of $5 million.

Kuehn Law is investigating whether the Board of the target company:‍‍

1) acted to maximize shareholder value
2) failed to disclose material information
3) conducted a fair process

Notice to Shareholders:

‍

As shareholders, it's essential to understand the fiduciary duties of the Board of Directors. These duties ensure the Board acts in the best interest of the company and its shareholders.

‍

Directors' Fiduciary Duties

‍

1. Duty of Care

‍

Diligence: Make informed decisions by thoroughly reviewing information.

‍

Active Participation: Regularly attend and engage in board meetings.

‍

Expert Advice: Seek expert opinions when necessary.

‍

2. Duty of Loyalty

‍

Avoid Conflicts of Interest: Prioritize the company's interests over personal gain.

‍

Self-Dealing: Do not use the position for personal benefit.

‍

Confidentiality: Maintain the confidentiality of company information.

‍

3. Duty of Good Faith

‍

Honesty: Act with integrity in all decisions.

‍

Best Interests: Ensure actions are in the best interest of the company and shareholders.

‍

Fairness: Treat all shareholders fairly and equally.

‍

Your awareness and understanding of these duties are crucial in ensuring the Board acts responsibly and in the best interest of all shareholders.

‍